NWPF

News Archives

Filtered by: January 2005

GB Therapeutics acquires a Phase 3, Parkinson’s Disease molecule

Thursday January 27, 2005

Anthony Giovinazzo, President & CEO of GB Therapeutics Ltd. (GBt), announced today that GBt has entered into an agreement with Chiesi Farmaceutici S.p.A. headquartered in Parma, Italy, for an exclusive license to Chiesi’s CHF1512 molecule which will result in an equity investment by Chiesi in GBt. The compound is a methyl-ester of levodopa (LDME), melevodopa, combined with the decarboxylase inhibitor carbidopa. The phase 3 clinical development, for Parkinson’s Disease patients was completed in Europe, leading to the registration in Italy. Additional Phase 3 trials to meet FDA and ICH guidelines targeting motor fluctuations are expected to commence in Q1, 2006.

Read Aricle

Stem cells/New federal rules are needed

Thursday January 27, 2005

If you do a "stem cell" search with Google, a few minutes of perusing will reveal that the research scene is crackling with projects seeking to harness these remarkable cells for medicine. "Cord blood cells limit heart attack damage in animals," reads one headline. Another said, "Adipose-derived stem cells for repairing human skull defects reported." A third reported that, "ESC gene profiles show more highly expressed genes than adult cells."

Read Aricle

Can Weed Killers Trigger Parkinson’s?

Wednesday January 26, 2005

Despite years of research, nobody knows what causes Parkinson’s disease. Some suspect toxins in the environment could trigger it, maybe even something around your house. Dr. Dean Edell says Bay Area scientists are trying to unravel the mystery.

Read Aricle

Van Andel Institute to research Parkinson’s disease

Tuesday January 25, 2005

At the time of his death, Amway Corp. co-founder and philanthropist Jay Van Andel had lived with Parkinson’s disease for about nine years.

Read Aricle

Michael J. Fox Foundation Joins With Community Partners to Award $3.6 Million for Innovative Parkinson’s Research

Tuesday January 25, 2005

After issuing an open call to researchers from around the world, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced today that it has awarded grants to 18 research teams that submitted new and novel ideas to advance the study of Parkinson’s disease. Projects range from new treatment
approaches including experimental neuroprotective therapies, to studies that could yield important insights into the etiology of Parkinson’s disease. The grants totaling more than $3.6 million were awarded through the Foundation’s 2004 Community Fast Track Program (CFT ’04). More than 40 percent of the applicants had never before sought funding from the Foundation.

Read Aricle

Scientists Detect Probable Genetic Cause Of Some Parkinson’s Disease Cases

Tuesday January 25, 2005

Two new studies strongly suggest that a mutation in a recently discovered gene is the most common genetic cause of Parkinson’s disease identified to date. The discovery by an international research team provides fresh evidence that genetics may contribute to the development of some cases of Parkinson’s disease. The findings could lead to the development of a genetic test to detect the mutation in individuals at risk . The research team includes investigators at the National Institute on Aging (NIA) and scientists supported by the National Institute of Neurological Disorders and Stroke (NINDS).

Read Aricle

Smoking May Protect Against Parkinson’s

Tuesday January 25, 2005

A study in Swedish twins confirms that smoking is associated with a reduced risk of Parkinson’s disease.

"The association in part is explained by genetic influences," Dr. Nancy L. Pedersen from the Karolinska Institute, Stockholm, told Reuters Health. "Hence, further attempts to study risk factors in general for Parkinson’s disease should entertain the possibility that there are complex interactions between genetic mechanisms and putative risk factors."

Read Aricle

The Parkinson’s Action Network 11th Annual Research and Education Forum & Public Policy Forum will be webcast live February

Tuesday January 25, 2005

For a schedule of webcast events, cut and paste this address in to your web browswer: http://event.netbriefings.com/
event/pan/Live/webcast/

Read Aricle

Michael J Fox happy despite battle against Parkinson’s Disease

Tuesday January 25, 2005

The ’Back To The Future’ star has undergone various therapies for the illness, which he was diagnosed with 14 years ago, and judging by the fun-filled holiday he is having with wife Tracy, it seems to be working.

Read Aricle

New treatment for Parkinson’s disease

Tuesday January 25, 2005

As many as 1 million Americans have Parkinson’s disease. There are several treatment options for symptoms, but they also come with side effects.

Now doctors may have a way to actually reverse the disease.

Read Aricle
<< Back 1 - 10 of 41 Next >>